Low- Versus High-Dose Methylprednisolone in Adult Patients With Coronavirus Disease 2019: Less Is More.

Seema JoshiZachary SmithSana SomanSaniya JainAtheel YakoMarwa HojeijLouis MassoudAyman AlsaadiJonathan WilliamsRachel KenneyJoseph B MillerGeorge AlangadenMayur Ramesh

Published in: Open forum infectious diseases (2021)

Low-dose methylprednisolone had comparable outcomes including mortality to high-dose methylprednisolone for the treatment of severe COVID-19.

Keyphrases

high dose
coronavirus disease
low dose
stem cell transplantation
sars cov
respiratory syndrome coronavirus
cardiovascular events
early onset
risk factors
type diabetes
metabolic syndrome
drug induced
adipose tissue